
Lupin Limited has informed the Exchange regarding a press release dated Jun 02, 2021, titled "Lupin announces U.S. FDA acceptance for Pegfilgrastim Biosimilar application.".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated Jun 02, 2021, titled "Lupin announces U.S. FDA acceptance for Pegfilgrastim Biosimilar application.".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin